AltPep Stock
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Sign up today and learn more about AltPep Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About AltPep Stock
AltPep Corp is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases.
Funding History
| January 2021 | $23.1M |
|---|
Management
Board Member
David Goel
Board Member
Joel Marcus
Press
geekwire - Apr, 8 2024
Vote for Startup CEO of the Year: These five leaders are taking their companies to new heightsfinance - Feb, 19 2024
AltPep Further Strengthens Advisory Board with Appointment of Steven E. Kahn, M.B., Ch.B.labpulse - Dec, 20 2023
Rome Therapeutics raises $72M in series B financinggeekwire - Dec, 20 2023
Biotech startup developing tests and treatments for ...425business - Dec, 20 2023
Second Quarter VC Activity, Value Down in Region, NationEquityZen Recognized As:
